Recent Change of -2.40% in the Ampio Pharmaceuticals Inc. (AMPE) market price might lead to pleasant surprises

Let’s start up with the current stock price of Ampio Pharmaceuticals Inc. (AMPE), which is $0.83 to be very precise. The Stock rose vividly during the last session to $1.00 after opening rate of $0.99 while the lowest price it went was recorded $0.83 before closing at $0.85.

Ampio Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.3900 on 09/21/20, with the lowest value was $0.3100 for the same time period, recorded on 03/25/20.


My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<

Sponsored


Ampio Pharmaceuticals Inc. (AMPE) full year performance was 64.46%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ampio Pharmaceuticals Inc. shares are logging -40.64% during the 52-week period from high price, and 217.33% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.26 and $1.39.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2157791 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Ampio Pharmaceuticals Inc. (AMPE) recorded performance in the market was 44.99%, having the revenues showcasing 51.87% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 151.27M, as it employees total of 23 workers.

Market experts do have their say about Ampio Pharmaceuticals Inc. (AMPE)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7144, with a change in the price was noted +0.2589. In a similar fashion, Ampio Pharmaceuticals Inc. posted a movement of +45.72% for the period of last 100 days, recording 3,613,464 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AMPE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Ampio Pharmaceuticals Inc. (AMPE)

Raw Stochastic average of Ampio Pharmaceuticals Inc. in the period of last 50 days is set at 26.56%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.56%. In the last 20 days, the company’s Stochastic %K was 35.01% and its Stochastic %D was recorded 48.52%.

Bearing in mind the latest performance of Ampio Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 44.99%. Additionally, trading for the stock in the period of the last six months notably improved by 135.20%, alongside a boost of 64.46% for the period of the last 12 months. The shares increased approximately by -3.94% in the 7-day charts and went down by 16.59% in the period of the last 30 days. Common stock shares were driven by 51.87% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the Investchronicle.com pre-market morning brief 100% free